March Biosciences
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$47M
Total Funding Raised
$45.88M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
March Biosciences operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A round in October 2024.
March Biosciences is a biotechnology company that develops CAR-T cell therapies for the treatment of hematological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
March Biosciences Comparables
Compare March Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allotera Therapeutics | 78% | |
| Beam Therapeutics | 74% | |
| Roche Holding | 74% |
For institutional investors. Book with your work email.
March Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Nov 15, 2023 | ||||
| VC Round | Nov 9, 2023 | ||||
| Seed | Jun 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
March Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| 4BIO Capital | Series A |
| The University of Texas MD Anderson Cancer Center | VC Round, Series A |
| CANCER FUND | Series A |
| Texas Medical Center Venture Fund | Seed |
| Cancer Focus Fund | Series A, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 33% MoM, reaching 3.5K.
- Apr 24, 2026
Grew 19% QoQ, from 21 to 25 employees.
For institutional investors. Book with your work email.
March Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about March Biosciences's valuation, stock price, and market status.
Is March Biosciences a public or private company?
March Biosciences is a private company.
What is the current stock price of March Biosciences?
March Biosciences is a private company, so its shares have no public market price. Caplight tracks March Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is March Biosciences worth (valuation)?
March Biosciences's valuation is estimated at $47.0M based on funding round data.
Can I buy March Biosciences stock?
March Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was March Biosciences's last funding round?
March Biosciences's most recent funding round was Series A on October 23, 2024.
Who are the main investors in March Biosciences?
Key investors in March Biosciences include 4BIO Capital, Texas Medical Center Venture Fund, Cancer Focus Fund, Mission BioCapital, Portal Innovations.
Will March Biosciences IPO soon?
No public IPO plans have been announced for March Biosciences.
How can I track March Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in March Biosciences's shares on secondary markets.